Distribution in cytogenetically defined prognostic subgroups (according to MRC)49
| Cytogenetic subgroup . | Total cohort (n = 1414) . | IDH1R132 wild-type . | IDH1R132 mutated . |
|---|---|---|---|
| Favorable | 229/16.2% | 227/99.1% | 2/0.9% |
| Intermediate | 779/55.1% | 698/89.6% | 81/10.4% |
| Unfavorable | 406/28.7% | 396/97.5% | 10/2.5% |
| Cytogenetic subgroup . | Total cohort (n = 1414) . | IDH1R132 wild-type . | IDH1R132 mutated . |
|---|---|---|---|
| Favorable | 229/16.2% | 227/99.1% | 2/0.9% |
| Intermediate | 779/55.1% | 698/89.6% | 81/10.4% |
| Unfavorable | 406/28.7% | 396/97.5% | 10/2.5% |
Significant difference (P < .001).